The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
Neal Shore, MD, FACS, shares his final thoughts on the current landscape of clinical trials for both non-muscle-invasive bladder cancer and muscle-invasive bladder cancer, providing insights into the potential impact and future directions of these studies.
Implementing a claims-based algorithm and disease management program may be an effective strategy to reduce relapse and cost among patients with schizophrenia.
Routine preoperative MRSA screening of cardiac surgery patients could provide substantial economic value to third-party payers and hospitals under a wide range of circumstances.
This study shows automatic, practical, simple, and effective strategies designed in the laboratory, in consensus with requesting clinicians, to improve laboratory test appropriateness.
This editorial discusses the cost implication of bariatric surgery and whether or not return on investment analysis should be used to make coverage decisions.
Hybrid approaches allow for clinician input into case finding for care management, but training and monitoring is required to protect against unintentional biases.
Substantial outreach efforts are needed in addition to offering subsidies or incentives in engaging primary care providers to adopt electronic health records.
Among a diabetes group visit population, this study found substantial savings in outpatient charges due to reduction in the use of more expensive specialty visits.
Gaps in ACO implementation readiness are identified as appointment reminders, referral follow-ups, care management, care transition alerts, clinical quality measure knowledge, and resources.
Among HealthPartners plan members, musculoskeletal, psychosocial, and neurologic conditions create the greatest burden to current health; diet offers the greatest opportunity to improve future health scores; and 42% report a high level of well-being.
The Perfect Depression Care initiative serves as an example of how suicide prevention programs can collect real-time mortality data internally to drive rapid quality improvement.
Retrospective analysis of value-based insurance design (VBID) showed the potential for VBID to improve adherence and reduce utilization and costs with active disease management counseling.
Hispanic patients with Medicaid were more likely to be admitted for ambulatory care–sensitive conditions after Nevada’s Medicaid expansion.
This article examines the evolution of the Community Hospital Acceleration, Revitalization and Transformation investment program in Massachusetts and informs other states seeking to transform care delivery in community hospitals toward value-based care.
This case study from the National Viral Hepatitis Roundtable and Project Inform describes the cost-sharing mechanisms that create significant barriers to accessing new hepatitis C treatments, which require a strong advocate response to improve patient access.
Nonadherence is common among high-risk patients initiating statins and is associated with suboptimal low-density lipoprotein cholesterol (LDL-C) reduction. LDL-C should be monitored to identify suboptimal response and medication nonadherence.
This study examines variation among health plans in resource use and quality of care for patients with diabetes mellitus or cardiovascular disease.
Analysis of studies of worksite wellness programs suggested mixed impact on health-related behaviors and cost, with insufficient evidence regarding absenteeism and mental health.